Status:
COMPLETED
Mobile App of CBT for Anxiety and Cancer
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Cancer
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The proposed study seeks to implement a randomized controlled trial to evaluate the effectiveness and generalizability of an efficacious cognitive-behavioral therapy (CBT) intervention for use as a se...
Detailed Description
Background: Patients with advanced cancer often experience marked anxiety symptoms that are associated with poor quality of life, high physical symptom burden, and complications with medical treatment...
Eligibility Criteria
Inclusion
- Diagnosis of a metastatic solid tumor
- Report clinically significant anxiety symptoms (i.e., Hospital Anxiety and Depression Scale (HADS) -Anxiety Subscale \> or equal to 8)
- Anxiety is principal psychiatric problem
- At least four weeks after cancer diagnosis
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
- Age greater than 18 years
- Ability to read and respond to questions in English
Exclusion
- Co-morbid delirium, dementia, or active and untreated major psychiatric condition such as schizophrenia will be excluded from the study
Key Trial Info
Start Date :
February 18 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 25 2016
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT02286466
Start Date
February 18 2015
End Date
October 25 2016
Last Update
August 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114